Mucopolysaccharidosis (Storage Disease, Metabolic Disorders Due to Enzyme Deficiency) in cats

Content

When to visit the vet?

Non-urgent see a veterinarian within 2–3 days

?

If the condition worsens / symptoms persist, consult a veterinarian.

Download/Print

Definition

Mucopolysaccharidosis (MPS) in cats is a genetic metabolic disease caused by a deficiency of specific enzymes. These enzymes are necessary for the breakdown of mucopolysaccharides, also called glycosaminoglycans, which accumulate in body cells and lead to various health problems.

The most important facts at a glance

Mucopolysaccharidosis (MPS) is a lysosomal storage disease in cats caused by an enzyme deficiency. This deficiency prevents the breakdown of glycosaminoglycans (GAGs), leading to the accumulation of these substances in cells and causing cell and organ damage. The disease is inherited through an autosomal recessive genetic mutation that must come from both parents for a cat to develop symptoms. Typical symptoms include stunted growth, bone disease and skeletal deformities, restricted joint mobility, congestive heart failure, and shortness of breath. Diagnosis is made through clinical signs, X-rays, and specific laboratory tests that measure enzyme activity and can detect elevated GAG concentrations in urine. Genetic tests help identify the specific mutation and are important for breeders to recognize carriers of the mutation. Treatment focuses on relieving symptoms through physiotherapy, pain medication, and in some cases enzyme replacement therapies or surgical interventions. The prognosis varies depending on the severity of the disease; while some cats can lead a relatively normal life, life expectancy in severe forms is often shortened. For prevention, it is important to conduct targeted breeding programs and use genetic tests to prevent the spread of the disease. Another preventive approach is educating breeders and cat owners about the disease and the importance of regular veterinary examinations.

Causes

Mucopolysaccharidosis belongs to a group of diseases known as lysosomal storage diseases. These diseases arise from a defect or deficiency of a specific lysosomal enzyme normally responsible for breaking down certain substances. In MPS, this involves the breakdown of glycosaminoglycans (GAGs), which consist of long chains of sugar molecules.

These GAGs are important components of connective tissues, cartilage, and other structures in the body. Normally, they are continuously broken down and renewed. In cats with MPS, the enzyme deficiency means these substances cannot be properly broken down and accumulate in the cells. This accumulation leads to progressive damage to cells, tissues, and organs.

The cause of MPS is a mutation in one of the genes responsible for producing the required enzymes. This genetic mutation is inherited in an autosomal recessive manner, meaning a cat must inherit the mutation from both parents to develop symptoms of the disease.

Symptoms

The symptoms of MPS in cats are diverse and vary depending on the severity and specific type of the disease. The most common signs include skeletal deformities such as shortened limbs or spinal deformities, which can lead to restricted movement. Cats may also suffer from growth delays.

Other symptoms include cloudy eyes or corneal opacities, which can lead to visual disturbances. Some cats show neurological symptoms such as ataxia (coordination disorders) or convulsions. Breathing problems caused by narrowed airways are also possible.

In severe cases, heart problems can occur, including heart valve disease. The accumulation of GAGs in internal organs can also cause liver and spleen enlargement, leading to further health complications.

Diagnosis

Diagnosis of MPS in cats is based on a combination of clinical signs, X-rays, and specific laboratory tests. A thorough physical examination can provide clues to skeletal and eye changes. X-rays can reveal skeletal abnormalities typical of MPS.

To confirm the diagnosis, specific laboratory tests are necessary to measure the activity of the affected enzymes. These tests can be performed on blood samples or skin biopsies. Additionally, urine samples can be examined for the presence of elevated GAG concentrations.

Genetic tests are also available and can help identify the specific mutation that causes MPS. These tests are particularly useful for breeders to identify carriers of the mutation and prevent the spread of the disease.

Therapy

Treatment of MPS in cats focuses on relieving symptoms and improving quality of life, as there is currently no cure for the disease. Physiotherapy and pain medication can help improve mobility and relieve pain.

In some cases, enzyme replacement therapies may be considered to compensate for the deficiency of certain enzymes. However, these therapies are still in the developmental stage and not widely available.

Additionally, surgical intervention may be necessary to address specific problems, such as removal of cloudy corneal tissue or correction of severe skeletal deformities. Regular veterinary examinations are crucial to monitor the progression of the disease and adjust treatment accordingly.

Prognosis and follow-up care

The prognosis for cats with MPS varies considerably depending on the type of disease and the severity of symptoms. While some cats with mild forms of the disease can lead a relatively normal life, life expectancy in more severe forms is often greatly reduced.

Affected cats typically require lifelong treatment and monitoring to maintain their quality of life. Early diagnosis and timely treatment can help relieve symptoms and extend lifespan. Nevertheless, MPS remains a progressive disease that ultimately leads to deteriorating health.

Prevention

For prevention of mucopolysaccharidosis in cats, targeted breeding programs are of crucial importance. Since this is a genetic disease, avoiding the mating of affected cats or those identified as carriers is an effective measure. Genetic tests can help identify carriers of the disease, even if they show no symptoms.

Another preventive approach is educating breeders and cat owners about the importance of genetic testing and the potential risks of the disease. By raising awareness of this metabolic disorder, informed decisions can be made in breeding. Additionally, education about the disease can help ensure that affected cats are identified early and receive the best possible support.

Regular veterinary examinations also play an important role in monitoring the cat’s overall health and detecting potential problems early. Although there is no cure, these measures can help reduce the spread of the disease within cat populations and improve the quality of life of affected animals.

Frequently asked questions (FAQs)